Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs

by Bishal Gyawali, Spencer P. Hey, Aaron S. Kesselheim
Published 2020-04-01

The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders

by Stuart G. Nicholls, Kelly Carroll, Merrick Zwarenstein, Jamie C. Brehaut, Charles Weijer, Spencer P. Hey, Cory E. Goldstein, Ian D. Graham, Jeremy M. Grimshaw, Joanne E. McKenzie, Dean A. Fergusson, Monica Taljaard, on behalf of the Ethics of Pragmatic Trials project
Published 2019-12-01